Mysterious Perlmutter-Helmed Start-Up Eikon Raises $517.8m
New Executive Team Members Also Announced
Eikon launched in 2021 with $148m in series A venture capital and former Merck R&D head Roger Perlmutter as its CEO, but even with half a billion dollars in fresh cash, the firm has not revealed its therapeutic focus.
